A low gamma-glutamyl transferase result is rarely a liver warning sign. The useful question is whether the rest of your liver panel, nutrition history, medicines, and symptoms tell a different story.
មគ្គុទេសក៍នេះត្រូវបានសរសេរក្រោមការដឹកនាំដោយ លោកវេជ្ជបណ្ឌិត Thomas Klein, MD ដោយសហការជាមួយ ក្រុមប្រឹក្សាប្រឹក្សាវេជ្ជសាស្ត្រ Kantesti AI, រួមទាំងការចូលរួមចំណែកពីសាស្ត្រាចារ្យវេជ្ជបណ្ឌិត Hans Weber និងការពិនិត្យផ្នែកវេជ្ជសាស្ត្រដោយវេជ្ជបណ្ឌិត Sarah Mitchell, MD, PhD។.
ថូម៉ាស គ្លីន, MD
ប្រធានផ្នែកវេជ្ជសាស្ត្រ, Kantesti AI
លោកវេជ្ជបណ្ឌិត Thomas Klein ជាវេជ្ជបណ្ឌិតឯកទេសជំងឺឈាមដែលមានវិញ្ញាបនបត្រពីក្រុមប្រឹក្សា និងជាវេជ្ជបណ្ឌិតផ្នែកជំងឺខាងក្នុង ដែលមានបទពិសោធន៍ជាង 15 ឆ្នាំក្នុងវិស័យវេជ្ជសាស្ត្រមន្ទីរពិសោធន៍ និងការវិភាគផ្នែកព្យាបាលដែលជួយដោយ AI។ ក្នុងតួនាទីជានាយកវេជ្ជសាស្ត្រ (Chief Medical Officer) នៅ Kantesti AI លោកផ្តល់ការត្រួតពិនិត្យផ្នែកវេជ្ជសាស្ត្រលើភាពត្រឹមត្រូវនៃសុខភាពនៃបណ្តាញសរសៃប្រសាទដែលជាកម្មសិទ្ធិ។ លោកវេជ្ជបណ្ឌិត Klein បានបោះពុម្ពផ្សាយលើការបកស្រាយ biomarker និងការធ្វើរោគវិនិច្ឆ័យក្នុងមន្ទីរពិសោធន៍។.
សារ៉ា មីឆែល, វេជ្ជបណ្ឌិត, បណ្ឌិត
ទីប្រឹក្សាវេជ្ជសាស្ត្រជាន់ខ្ពស់ - រោគវិទ្យាគ្លីនិក និងវេជ្ជសាស្ត្រផ្ទៃក្នុង
លោកស្រីវេជ្ជបណ្ឌិត Sarah Mitchell គឺជាគ្រូពេទ្យឯកទេសរោគវិទ្យាគ្លីនិក (clinical pathologist) ដែលមានវិញ្ញាបនបត្របញ្ជាក់ពីក្រុមប្រឹក្សាវេជ្ជសាស្ត្រ និងមានបទពិសោធន៍ជាង 18 ឆ្នាំក្នុងវិស័យវេជ្ជសាស្ត្រមន្ទីរពិសោធន៍ និងការវិភាគផ្នែករោគវិនិច្ឆ័យ។ លោកស្រីមានវិញ្ញាបនបត្រឯកទេសក្នុងគីមីវិទ្យាគ្លីនិក (clinical chemistry) ហើយបានបោះពុម្ពយ៉ាងទូលំទូលាយលើបន្ទះសញ្ញាសម្គាល់ជីវសាស្ត្រ និងការវិភាគក្នុងមន្ទីរពិសោធន៍ក្នុងការអនុវត្តព្យាបាល។.
សាស្ត្រាចារ្យបណ្ឌិត ហាន់ វេប៊ើរ បណ្ឌិត
សាស្ត្រាចារ្យផ្នែកវេជ្ជសាស្ត្រមន្ទីរពិសោធន៍ និងជីវគីមីគ្លីនិក
សាស្ត្រាចារ្យវេជ្ជបណ្ឌិត Hans Weber មានជំនាញជាង 30+ ឆ្នាំក្នុងជីវគីមីវិទ្យាគ្លីនិក (clinical biochemistry) វេជ្ជសាស្ត្រមន្ទីរពិសោធន៍ និងការស្រាវជ្រាវសញ្ញាសម្គាល់ជីវសាស្ត្រ (biomarker research)។ អតីតប្រធានសមាគមគីមីវិទ្យាគ្លីនិកអាល្លឺម៉ង់ (German Society for Clinical Chemistry) លោកមានជំនាញពិសេសលើការវិភាគបន្ទះរោគវិនិច្ឆ័យ (diagnostic panel analysis) ការធ្វើស្តង់ដារសញ្ញាសម្គាល់ជីវសាស្ត្រ (biomarker standardization) និងការវិភាគវេជ្ជសាស្ត្រមន្ទីរពិសោធន៍ដែលជួយដោយ AI។.
- Low GGT levels are usually benign when ALT, AST, ALP, bilirubin, albumin, and symptoms are unremarkable.
- ចន្លោះយោងប្រែប្រួល: many adult laboratories report roughly 5-55 U/L, but some do not flag a low GGT at all.
- A value below 5 U/L is usually an assay-floor or individual-baseline finding, not evidence of liver failure.
- Low gamma glutamyl transferase can accompany low oxidative exposure, lower body mass, hormonal effects, or certain medications, although the evidence is not strong enough to diagnose any one cause.
- Rare inherited GGT deficiency causes glutathionuria and broader clinical clues; an isolated low serum result does not establish this diagnosis.
- ALP context matters: a normal or low GGT with raised ALP makes a bone source more likely than a bile-duct source.
- Nutrition testing should be targeted: low GGT alone does not prove zinc, protein, vitamin B6, or antioxidant deficiency.
- Repeat testing is reasonable when a result is unexpected, but urgent care is not needed for low GGT alone without concerning symptoms.
What a Low GGT Blood Result Usually Means
Low GGT levels are almost always a reassuring finding rather than a disease signal, particularly when bilirubin, alkaline phosphatase (ALP), ALT, and AST are within the reporting laboratory's range. A low gamma-glutamyl transferase does not mean that the liver has “stopped working”; impaired liver synthesis is assessed with albumin, INR, bilirubin, platelets, and clinical findings—not a low GGT alone.
GGT is a membrane-associated enzyme concentrated in the biliary epithelium, kidney tubules, pancreas, and several other tissues. Laboratories mainly use it as a supporting marker of enzyme induction or cholestatic stress, which is why clinical attention is usually directed toward high, not low, values. The EASL cholestasis guideline uses GGT alongside ALP and bilirubin when evaluating a cholestatic pattern; it does not define an adverse lower GGT threshold (EASL, 2009).
In my clinical work, a result such as GGT 4 U/L with ALT 18 U/L, ALP 72 U/L, and bilirubin 9 µmol/L needs explanation, not alarm. It commonly reflects normal biology, a laboratory method that reports down to 3 or 5 U/L, or an individual who has little enzyme induction from alcohol, metabolic liver stress, or medicines. For the wider context of a liver panel, see our guide to what liver tests include.
As of September 25, 2026, no major liver guideline recommends treatment, imaging, or a special diet solely because GGT is below range. Dr. Thomas Klein, Kantesti's Chief Medical Officer, advises patients to first verify the unit, reference interval, and neighboring results before pursuing deficiency testing. Kantesti is an AI blood test analyzer that reads low GGT alongside the full liver-panel pattern rather than treating a single low number as a diagnosis.
Why GGT Reference Ranges Differ Between Laboratories
There is no universal lower cutoff for GGT, because methods, calibration, sex distribution, and local reference populations differ. Many adult laboratories quote approximately 5-55 U/L, while others use 7-49 U/L for women and 10-71 U/L for men or simply report values below the assay limit as low.
GGT is generally measured by a kinetic colorimetric assay that detects the rate of substrate conversion at 37°C. A reported result of “<3 U/L” is not the same as a precisely measured value of 0 U/L; it often means the activity was below the method's reliable quantification boundary. That distinction is easy to miss when patient portals automatically apply a low flag.
Sex, age, alcohol exposure, adiposity, and laboratory selection criteria shift the upper end of a GGT interval much more than the lower end. A 24-year-old woman with GGT 3 U/L and a 68-year-old man with GGT 3 U/L can both be well, provided the wider panel is coherent. Read the laboratory’s own interval rather than borrowing a number from a search result; our ជួរ GGT explains the common unit and sex differences.
Kantesti AI compares reported values with the laboratory-specific range whenever it is visible on an uploaded report, then checks whether the apparent low value is analytically meaningful. Kantesti is an AI blood test interpretation platform designed to identify when a flagged result conflicts with the actual clinical pattern. A one-point difference around an assay floor rarely represents a meaningful biological change.
When Low GGT Levels Are Entirely Benign
Low GGT is generally benign when it is isolated and stable over time. A person with GGT 2-6 U/L, normal ALP and bilirubin, no jaundice or persistent itch, and normal nutrition does not usually need a liver work-up because of that value.
The most useful clinical clue is stability. If GGT has been 4, 5, and 3 U/L over 4 years while ALT remains below 30 U/L and ALP below 120 U/L, that is more persuasive evidence of a personal baseline than one isolated draw. Biological variation affects enzymes, but values close to the lower analytic boundary may appear to bounce by 1-2 U/L without any biological consequence.
I see this after preventive panels in physically active people who do not drink alcohol and take few medicines. One 52-year-old trail runner had GGT 4 U/L, AST 46 U/L after a mountain race, and normal bilirubin; the muscle-related AST rise—not the low GGT—was what needed a repeat after 7 days without strenuous exercise. Our article on high AST after exercise gives useful context for that different pattern.
A normal GGT does not rule out every liver condition, and a low result certainly does not provide a “liver health score.” It simply has weak negative clinical meaning by itself. If you feel well and your other results are normal, save the date, fasting status, recent exercise, and medicines for comparison at your next តេស្តឈាមមូលដ្ឋាន.
Nutrition, Weight Loss and Low GGT Claims
Low GGT levels do not diagnose poor nutrition, antioxidant deficiency, or “liver detoxification.” Severe undernutrition can affect many liver-related proteins and enzymes, but low GGT alone is neither sensitive nor specific enough to identify a nutrient shortfall.
GGT participates in extracellular glutathione metabolism, which has led to attractive but oversimplified online claims that a low value proves low glutathione, zinc deficiency, or inadequate protein intake. Human serum GGT activity is not a validated proxy for tissue glutathione stores. A person with poor protein intake is more likely to show clues such as low weight, reduced muscle mass, anemia, low phosphate, low albumin in advanced illness, or specific vitamin deficiencies.
Rapid weight loss deserves a more nuanced reading. During calorie restriction, GGT often falls alongside reductions in liver fat and insulin resistance, yet transient ALT changes can occur during rapid weight loss or heavy exercise. If fatigue, restrictive eating, missed periods, recurrent injuries, or low ferritin coexist, the priority is a broader nutrition assessment; our មគ្គុទេសក៍មន្ទីរពិសោធន៍សម្រាប់អត្តពលិកដែលហាត់យូរ describes practical screening patterns.
Dr. Thomas Klein has seen patients spend substantial sums on antioxidant panels after a GGT of 4 U/L, only to find that their CBC, ferritin, vitamin B12, thyroid tests, and diet history were the real clinical leads. Targeted testing beats supplement guessing. A low GGT blood result is not a reason to start glutathione, zinc, or high-dose vitamin supplements without a documented indication.
Medicines and Hormones That Can Lower GGT
Some medicines and hormonal states may lower GGT activity, but medication-related low GGT is usually clinically harmless. The practical issue is not to stop a prescribed treatment because one enzyme result falls below a reference interval.
Medication effects are far better established for elevated GGT than reduced GGT. Enzyme-inducing antiseizure medicines, for example, can raise GGT; conversely, improved metabolic control, reduced alcohol use, and some lipid-lowering therapies may reduce a previously higher value. A falling GGT after treatment is not automatically a direct drug effect—it may reflect the condition improving.
Oestrogen-containing contraception and pregnancy can alter several liver analytes, including GGT, but reference intervals for pregnancy are laboratory-dependent. In a person taking oral contraception with GGT 5 U/L, normal bilirubin, and no itching, the result usually requires no action. Persistent itch with raised bile acids in pregnancy is a different clinical question, covered in our bile-acid testing guide.
Bring a complete medication and supplement list to any repeat test, including antiseizure medicines, statins, antibiotics, herbal products, and hormonal treatments. Do not discontinue medication because of low gamma glutamyl transferase without discussing it with the prescriber. The risk of stopping an essential medicine is usually much greater than the significance of an isolated GGT of 3 U/L.
How to Read Low GGT Alongside Alkaline Phosphatase
Low or normal GGT with elevated ALP often points away from a liver or bile-duct source and toward bone, intestine, or pregnancy-related ALP. This pairing is one of the few situations where GGT meaningfully changes the interpretation of another result.
ALP comes mainly from liver and bone in adults. When ALP is elevated but GGT remains low-normal, clinicians often consider vitamin D deficiency, healing fracture, high bone turnover, hyperparathyroidism, adolescence, or pregnancy before ordering biliary imaging. A GGT of 6 U/L does not exclude liver disease, but it makes an isolated ALP of 155 U/L less suggestive of cholestasis when bilirubin is normal.
The reason this pair matters is biochemical: biliary epithelial stress commonly increases both ALP and GGT, whereas osteoblast activity increases ALP without necessarily changing GGT. EASL's 2009 cholestasis guideline supports using GGT to help establish hepatic origin when ALP is raised (EASL, 2009). For a focused discussion of bone-source ALP, read our guide to ALPបន្ទាប់ពីការបាក់ឆ្អឹង.
A 34-year-old with ALP 164 U/L, GGT 7 U/L, 25-hydroxyvitamin D 18 ng/mL, and normal bilirubin needs bone and vitamin D context—not reflex ultrasound. In contrast, ALP 260 U/L plus bilirubin 42 µmol/L and right-upper-abdominal pain warrants prompt clinical assessment even if GGT is unexpectedly low. Symptoms and the total pattern always outrank one enzyme.
Rare Inherited GGT Deficiency and Glutathionuria
True inherited GGT deficiency is exceptionally rare and is not diagnosed from a single low serum GGT value. It involves pathogenic changes affecting gamma-glutamyl transferase activity and may cause glutathionuria, neurological features, metabolic concerns, or abnormal findings from childhood.
The rare disorder sometimes called gamma-glutamyl transpeptidase deficiency affects glutathione processing and is evaluated with specialist biochemical and genetic testing. Published case descriptions include increased urinary glutathione, but the phenotype is variable and the evidence base is necessarily small because so few people are affected. An adult who feels well with an isolated GGT of 3 U/L is very unlikely to have this condition.
I would think about specialist referral only when the low result is persistent and there are additional clues: unexplained neurological or developmental symptoms, a childhood history of unusual metabolic findings, family members with a confirmed condition, or a report of abnormal urinary glutathione. Routine commercial genetic panels can produce uncertain variants, so they should not be interpreted without genetics expertise.
Kantesti's neural network can flag an unusually low GGT for contextual review, but it does not diagnose rare enzyme disorders from routine chemistry data. Kantesti is an AI-powered blood test analysis tool that identifies when low GGT coexists with other abnormalities that justify clinician-led follow-up. For laboratory questions that need careful method review, our ទិដ្ឋភាពទូទៅនៃការធ្វើឱ្យមានសុពលភាពផ្នែកវេជ្ជសាស្ត្រ ពន្យល់ពីដែនកំណត់នៃការបកស្រាយដោយស្វ័យប្រវត្តិ។.
Why Low GGT Does Not Mean Low Liver Function
Low GGT does not measure liver reserve, liver detoxification capacity, or liver failure. Liver synthetic function is better assessed using bilirubin, albumin, INR or prothrombin time, platelet trend, clinical examination, and—in selected cases—imaging or fibrosis evaluation.
GGT is an enzyme activity measurement, not a direct measure of hepatocyte mass. In advanced cirrhosis, GGT can be normal, high, or occasionally lower than expected depending on the cause and stage; therefore, neither a normal nor low GGT rules out chronic liver disease. New jaundice, confusion, abdominal swelling, black stools, or easy bruising require medical attention regardless of GGT.
When I review a panel, albumin below 35 g/L, bilirubin above 34 µmol/L, INR above 1.5 in someone not taking anticoagulants, and falling platelets are more clinically concerning than a GGT of 2 U/L. These are not stand-alone diagnoses either, but they point toward impaired synthesis, cholestasis, or portal hypertension more directly. Our guide to សញ្ញាដំបូងនៃជំងឺក្រិនថ្លើម គ្របដណ្តប់លំនាំទូលំទូលាយជាង។.
The phrase “liver enzyme” causes understandable confusion: ALT, AST, ALP, and GGT are injury, tissue-source, or induction markers—not a report card for overall organ performance. A low GGT blood result should never reassure someone away from urgent symptoms, and it should not create anxiety in an otherwise entirely normal panel.
Could a Low GGT Result Be a Testing Artifact?
A very low GGT result can reflect assay sensitivity, sample handling, or ordinary analytic variation, especially near 3-5 U/L. Repeating the test is reasonable when the result is unexpected or conflicts with the rest of the panel, but a same-day emergency redraw is rarely necessary.
Unlike potassium or glucose, GGT is not usually one of the analytes most distorted by a brief delay in sample processing, yet every enzyme assay has imprecision near its lower measuring limit. A result changing from 4 U/L to 7 U/L may be entirely compatible with analytic and within-person variation. Compare the laboratory, units, fasting state, recent exercise, and medicines before interpreting a small shift.
Hemolysis, lipemia, and icterus can interfere with some laboratory measurements, but their effect depends on the exact analyzer and assay chemistry. A report that labels the specimen as hemolyzed or unsuitable should prompt laboratory-specific advice rather than assumptions. Our ការធ្វើតេស្តឡើងវិញបន្ទាប់ពីការណែនាំ hemolysis explains why a redraw can clarify selected panels.
If a low GGT is isolated, repeating it with the next routine panel in 3-12 months is usually sufficient. Repeat sooner—often within 2-8 weeks—if ALP, bilirubin, ALT, or symptoms are changing, not because the GGT itself is low. Record the exact value; “low” is a flag, not a clinical measurement.
Symptoms That Matter More Than a Low GGT Number
Symptoms change the plan when they suggest liver, biliary, gastrointestinal, or systemic illness; low GGT itself causes no recognized symptom syndrome. Yellow eyes, dark urine, pale stools, fever with abdominal pain, persistent generalized itch, or new confusion need prompt clinical assessment even if GGT is below range.
Bile-duct obstruction can present with pain, jaundice, dark urine, pale stool, and rising bilirubin or ALP. A low GGT would be unusual in that pattern but would not make it safe to wait. The same principle applies to viral hepatitis, medication-associated liver injury, and gallbladder inflammation: the symptom trajectory and wider laboratory pattern lead the decision.
Systemic symptoms can point elsewhere. Unintentional weight loss of more than 5% over 6-12 months, chronic diarrhoea, recurrent vomiting, or marked fatigue may justify CBC, ferritin, thyroid testing, coeliac screening, and nutrition review even when GGT is low. For persistent digestive warning signs, see our article on undigested food and red flags.
I tell patients this plainly: an isolated GGT of 4 U/L is not an emergency, but a person with jaundice and severe pain is not “cleared” by it. Medical triage is based on the whole person. Bring your test report and a timeline of symptoms, alcohol intake, medicines, recent infections, and travel exposures.
Who Actually Needs Follow-Up for Low GGT?
Most adults need no follow-up for isolated low GGT, while a smaller group needs review because of associated abnormalities or a concerning clinical history. Follow-up is driven by the companion results, not by a numeric lower cutoff such as 5 U/L.
Arrange routine primary-care review if low GGT accompanies unexplained fatigue, marked dietary restriction, low BMI, repeated fractures, chronic diarrhoea, or other abnormal laboratory values. Consider timely review if ALP is raised, bilirubin is abnormal, albumin is low, INR is prolonged, or platelet count is falling. A low GGT with otherwise normal results generally does not require hepatology referral.
Children deserve a little more caution because reference intervals vary substantially with age, puberty, and laboratory method. A paediatrician should interpret persistently very low results in the setting of developmental, neurological, growth, or metabolic concerns. For families, our guide to safe age-based blood tests outlines why adult ranges cannot simply be copied onto children.
Kantesti AI supports result organization and trend review, but it cannot replace clinical examination or specialist assessment. If you are unsure whether a combination needs review, use a structured បញ្ជីត្រួតពិនិត្យពេលទៅជួបគ្រូពេទ្យ to list values, symptoms, family history, and current treatments.
A Practical Plan After Seeing Low GGT on Results
The practical response to low GGT is to confirm the laboratory range, inspect the full liver panel, review medicines and symptoms, and avoid unnecessary supplements. For an isolated value below range, this takes minutes and is usually more useful than ordering a large “detox” panel.
Start with five items: GGT value and unit; laboratory reference interval; ALT, AST, ALP, and bilirubin; albumin and platelet count if available; and symptoms. If all are reassuring, document the value as a likely personal baseline. If your report uses U/L, do not convert it to IU/L—these labels are generally used interchangeably for enzyme activity in routine reporting.
Next, list medication changes, hormonal therapy, alcohol pattern, major weight change, recent endurance exercise, pregnancy status, and supplements. This context helps distinguish a harmless low result from a panel that needs another look. Our មគ្គុទេសក៍ពេលវេលាសម្រាប់ការធ្វើតេស្តឈាម explains which life events can make one draw differ from the next.
Avoid “correcting” low GGT. There is no evidence-based target dose of zinc, glutathione, milk thistle, or B vitamins intended to raise GGT in a well person. If a nutritional concern exists, test and treat the relevant deficiency—for example, ferritin, vitamin B12, vitamin D, folate, zinc, or albumin—rather than chasing an enzyme number.
How Kantesti Interprets a Low GGT in Context
Kantesti interprets low GGT by checking the liver-panel pattern, reference interval, symptoms entered by the user, medications, and prior results—not by assigning a diagnosis to one low value. This approach is especially useful when the same report contains an ALP, bilirubin, ALT, or nutrition-related result that changes the clinical meaning.
Kantesti AI can process a laboratory-report PDF or photo and organize findings in roughly 60 seconds, while keeping the reported laboratory ranges visible for review. A low GGT is generally categorized as low clinical priority when it is isolated, then escalated for human discussion when paired with abnormalities such as high ALP, high bilirubin, low albumin, or concerning symptoms. Trend analysis is often more valuable than a single flagged result.
Our clinical team reviews medical content and safety boundaries; the ក្រុមប្រឹក្សាប្រឹក្សាវេជ្ជសាស្ត្រ provides physician oversight for how result explanations are framed. Kantesti is an AI lab test interpretation service that turns a low GGT result into a pattern-based question for the patient and clinician, rather than a misleading diagnosis. In our experience with more than 2 million interpreted reports, isolated low flags are a common source of avoidable worry.
The right endpoint is a better conversation with your clinician, not an automated verdict. Save the original report, note whether the test was fasting, and compare like with like over time. If you want to understand how our result-reading methodology handles reference intervals and uncertainty, review our មគ្គុទេសក៍បច្ចេកវិទ្យា AI.
Bottom Line: Low GGT Is Usually a Reassuring Finding
Low GGT levels almost never need treatment or urgent investigation on their own. The exception is not a particular low number; it is a low result appearing with other abnormal tests, significant symptoms, a relevant childhood or family history, or clear evidence of malnutrition.
Use the laboratory’s own reference interval and do not assume that a value of 3 U/L means the same thing across laboratories. A low value has very different implications from a high GGT, which is why guidance designed for elevated GGT should not be applied in reverse. The related overview of what GGT stands for may help when reading your report.
The most clinically useful question is, “What else is happening in this panel and in my life?” Normal ALP, bilirubin, ALT, AST, albumin, and platelets make an isolated low result reassuring. Symptoms such as jaundice, dark urine, persistent itching, fever, severe abdominal pain, confusion, or rapid weight loss deserve evaluation whether GGT is low, normal, or high.
Dr. Thomas Klein's practical advice is simple: do not supplement to raise GGT, do not stop medication because of it, and do not let a low flag overshadow more meaningful findings. For questions about the organisation and its clinical approach, see អំពី Kantesti.
សំណួរដែលសួរញឹកញាប់
តើកម្រិត GGT ទាបប៉ះពាល់ដល់សុខភាពដែរទេ?
កម្រិត GGT ទាបជាធម្មតាមិនអាក្រក់ទេ ហើយកម្របង្ហាញពីជំងឺថ្លើមនៅពេលលទ្ធផលថ្លើមផ្សេងទៀតមានលក្ខណៈធម្មតា។ គណនីជាច្រើនប្រើចន្លោះយោងសម្រាប់មនុស្សពេញវ័យដែលមានកម្រិតជិត 5-55 U/L ប៉ុន្តែមិនមានដែនកំណត់ទាបប្រកបដោយគ្រោះថ្នាក់ដែលត្រូវបានទទួលយកជាសកលទេ។ GGT 3-5 U/L ជាមួយនឹង ALT, AST, ALP, ប៊ីលីរុយប៊ីន, អាល់ប៊ុយមីន ដែលមានលក្ខណៈធម្មតា និងមិនមានរោគសញ្ញា គឺជាការរកឃើញដែលមិនបង្កគ្រោះថ្នាក់ជាទូទៅ។ ការពិនិត្យសុខភាពគឺសមរម្យនៅពេលដែល GGT ទាបកើតឡើងរួមជាមួយនឹងការធ្វើតេស្តមិនប្រក្រតីផ្សេងទៀត ការសម្រកទម្ងន់យ៉ាងច្រើន រោគសញ្ញា malabsorption ឬប្រវត្តិពាក់ព័ន្ធក្នុងវ័យកុមារភាព និងគ្រួសារ។.
តើអ្វីបណ្តាលឱ្យមានកម្រិតទាបនៃអង់ស៊ីមហ្គាម៉ា-គ្លូតាមីល ត្រង់ស្ស្ហ្វឺរ៉ាស់?
កម្រិតទាបនៃអង់ស៊ីម gamma glutamyl transferase អាចឆ្លុះបញ្ចាំងពីភាពប្រែប្រួលធម្មតារបស់បុគ្គល, សកម្មភាពវិភាគទាបនៅជិតដែនកំណត់នៃការរាយការណ៍នៃការវិភាគ, ការប៉ះពាល់ទាបទៅនឹងជាតិអាល់កុល ឬថ្នាំដែលជំរុញអង់ស៊ីម, បរិបទអ័រម៉ូន, ឬការប្រសើរឡើងនៃភាពតានតឹងនៃថ្លើមដែលទាក់ទងនឹងមេតាប៉ូលីស។ កង្វះអាហារូបត្ថម្ភធ្ងន់ធ្ងរអាចផ្លាស់ប្តូរតម្លៃមន្ទីរពិសោធន៍ជាច្រើន, ប៉ុន្តែ GGT ទាបតែមួយមុខមិនបញ្ជាក់ពីកង្វះប្រូតេអ៊ីន, ស័ង្កសី, វីតាមីន B6, គ្លូតាមីន, ឬសារធាតុប្រឆាំងអុកស៊ីតកម្មទេ។ កង្វះ GGT ដែលតំណពូជកម្រមាន, ប៉ុន្តែវាតែងតែពាក់ព័ន្ធនឹងសញ្ញាគ្លីនិក ឬមេតាប៉ូលីសបន្ថែម និងតម្រូវឱ្យមានការធ្វើតេស្តពីអ្នកជំនាញ។ តម្លៃទាបជាង 5 U/L ដោយខ្លួនឯងមិនគ្រប់គ្រាន់ដើម្បីធ្វើរោគវិនិច្ឆ័យមូលហេតុទេ។.
ខ្ញុំគួរព្រួយបារម្ភទេ ប្រសិនបើ GGT របស់ខ្ញុំមាន ១ U/L?
GGT 4 U/L ជាទូទៅមិនមែនជារឿងគួរឲ្យព្រួយបារម្ភទេ ប្រសិនបើវាមានលក្ខណៈដាច់ដោយឡែក ហើយបន្ទះមន្ទីរពិសោធន៍របស់អ្នកមានលក្ខណៈធម្មតា។ ទីមួយ សូមពិនិត្យមើលថាតើរបាយការណ៍មន្ទីរពិសោធន៍មានតម្លៃក្រោម 3 ឬ 5 U/L ជាដែនកំណត់នៃការវាស់វែងหรือไม่ ពីព្រោះភាពខុសគ្នាតិចតួចនៅក្នុងជួរនេះប្រហែលជាមិនមានន័យព្យាបាលទេ។ សូមពិនិត្យ ALP, ប៊ីលីរុយប៊ីន, ALT, AST, អាល់ប៊ុយមីន, ចំនួនប្លាកែត, ថ្នាំ និងរោគសញ្ញា ជាជាងការផ្តោតលើ GGT តែមួយមុខ។ ការធ្វើតេស្តឡើងវិញអាចរង់ចាំរហូតដល់បន្ទះធម្មតាបន្ទាប់ លុះត្រាតែលទ្ធផល ឬរោគសញ្ញាផ្សេងទៀតកំពុងផ្លាស់ប្តូរ។.
Can low GGT mean vitamin or mineral deficiency?
Low GGT does not reliably diagnose any vitamin or mineral deficiency. Although GGT is involved in glutathione metabolism, serum activity has not been validated as a clinical measure of zinc status, vitamin B6 status, protein intake, or antioxidant reserves. If symptoms suggest a nutritional problem, clinicians usually choose targeted tests such as ferritin, vitamin B12, folate, 25-hydroxyvitamin D, zinc, CBC, albumin, and phosphate. Taking supplements solely to raise a GGT result of 3-6 U/L is not evidence-based.
What does low GGT with high alkaline phosphatase mean?
Low or normal GGT with high alkaline phosphatase can suggest that the alkaline phosphatase comes from bone rather than liver or bile ducts. Vitamin D deficiency, healing fractures, high bone turnover, pregnancy, and adolescence are common contexts for this pattern. For example, ALP 160 U/L with GGT 6 U/L and vitamin D 18 ng/mL merits bone and vitamin D assessment before assuming bile-duct disease. Jaundice, dark urine, abdominal pain, or high bilirubin still need medical assessment regardless of GGT.
Can medications lower GGT?
Medications can be associated with lower GGT, although medicine-related GGT elevation is better established than medicine-related suppression. Improved metabolic health, reduced alcohol exposure, hormonal treatments, and treatment of a prior liver condition can all coincide with a lower value. Do not stop statins, antiseizure medicines, contraception, antibiotics, or supplements because a GGT result falls below 5 U/L without speaking to the prescriber. The full panel and reason for treatment matter more than a low isolated enzyme result.
ទទួលការវិភាគឈាមដោយ AI ដែលមានថាមពលថ្ងៃនេះ
ចូលរួមជាមួយអ្នកប្រើប្រាស់ជាង 2 លាននាក់នៅទូទាំងពិភពលោក ដែលទុកចិត្ត Kantesti សម្រាប់ការវិភាគលទ្ធផលតេស្តមន្ទីរពិសោធន៍ភ្លាមៗ និងត្រឹមត្រូវ។ ផ្ទុកឡើងលទ្ធផលពិនិត្យឈាមរបស់អ្នក ហើយទទួលការបកស្រាយយ៉ាងទូលំទូលាយនៃសញ្ញាសម្គាល់ (biomarkers) 15,000+ ក្នុងរយៈពេលប៉ុន្មានវិនាទី។.
📚 ឯកសារស្រាវជ្រាវដែលបានយោង
Klein, T., Mitchell, S., & Weber, H. (2026). ការធ្វើតេស្តឈាមសម្រាប់មេរោគ Nipah៖ ការណែនាំអំពីការរកឃើញ និងធ្វើរោគវិនិច្ឆ័យដំបូង ឆ្នាំ២០២៦.។ ការស្រាវជ្រាវវេជ្ជសាស្ត្រដោយ AI របស់ Kantesti។.
Klein, T., Mitchell, S., & Weber, H. (2026). មគ្គុទេសក៍ប្រភេទឈាម B អវិជ្ជមាន ការពិនិត្យឈាម LDH និងចំនួន Reticulocyte.។ ការស្រាវជ្រាវវេជ្ជសាស្ត្រដោយ AI របស់ Kantesti។.
📖 ឯកសារយោងវេជ្ជសាស្ត្រខាងក្រៅ
សមាគមអឺរ៉ុបសម្រាប់ការសិក្សាអំពីថ្លើម (2009)។. EASL Clinical Practice Guidelines: ការគ្រប់គ្រងជំងឺថ្លើមប្រភេទ cholestatic.។ Journal of Hepatology។.
Whitfield JB (2001). Gamma glutamyl transferase.។ ការពិនិត្យឡើងវិញដ៏សំខាន់ក្នុងវិទ្យាសាស្ត្រមន្ទីរពិសោធន៍គ្លីនិក។.
📖 បន្តអាន
ស្វែងយល់មគ្គុទេសក៍វេជ្ជសាស្ត្រដែលអ្នកជំនាញពិនិត្យឡើងវិញបន្ថែមពី Kantesti ក្រុមវេជ្ជសាស្ត្រ៖

ការធ្វើតេស្ត Total T3៖ ចំណុចសំខាន់ៗ និងដែនកំណត់នៃការធ្វើរោគវិនិច្ឆ័យ
ការពិនិត្យក្រពេញធីរ៉ូអ៊ីដ ការបកស្រាយលទ្ធផលមន្ទីរពិសោធន៍ ការធ្វើបច្ចុប្បន្នភាពឆ្នាំ ២០២៦ សម្រាប់អ្នកជំងឺ លទ្ធផល T3 សរុបអាចគាំទ្រដល់ការធ្វើរោគវិនិច្ឆ័យជំងឺក្រពេញទីរ៉ូអ៊ីតលើសសកម្ម ជាពិសេស...
អានអត្ថបទ →
ការធ្វើតេស្តរោគសញ្ញាខឹតស៊ីង: ការត្រួតពិនិត្យ ការបញ្ជាក់ និងជំហានបន្ទាប់
ការបកស្រាយលទ្ធផលនៃមន្ទីរពិសោធន៍ខាងអរម៉ូន endocrine 2026 បានធ្វើបច្ចុប្បន្នភាព រោគសញ្ញា Cushing ដែលងាយស្រួលដល់អ្នកជំងឺ ត្រូវបានធ្វើរោគវិនិច្ឆ័យដោយបង្ហាញពីការផលិតអរម៉ូន Cortisol លើសកម្រិតជាបន្តបន្ទាប់ជាមួយនឹង...
អានអត្ថបទ →
តើឈាមក្នុងលាមកមានន័យដូចម្តេច? ពណ៌និងភាពបន្ទាន់
ការវាយតម្លៃរោគសញ្ញាសុខភាពរំលាយអាហារឆ្នាំ 2026 បច្ចុប្បន្នភាព ពណ៌លាមកដែលងាយយល់សម្រាប់អ្នកជំងឺអាចជួយរកទីតាំងនៃការហូរឈាមក្នុងប្រព័ន្ធរំលាយអាហារ ប៉ុន្តែពណ៌តែឯងមិនអាច...
អានអត្ថបទ →
លទ្ធផលទឹកនោម៖ កោសិកា គ្រីស្តាល់ និងជំហានបន្ទាប់
ការបកស្រាយលទ្ធផលវិភាគទឹកនោម 2026 បច្ចុប្បន្នភាពការពិនិត្យមីក្រូទស្សន៍ទឹកនោមដែលងាយស្រួលយល់មានប្រយោជន៍បំផុតនៅពេលអ្នកអានលំនាំទាំងមូល៖ ការប្រមូល...
អានអត្ថបទ →
ការធ្វើតេស្តឈាមរកសារប្រឆាំងអុកស៊ីតកម្ម: អត្ថន័យពិតប្រាកដនៃលទ្ធផល
ការបកស្រាយលទ្ធផលការពិសោធន៍ស្ត្រេសអុកស៊ីតកម្ម ការអាប់ដេតឆ្នាំ 2026 កំណែសម្រាប់អ្នកជំងឺ លទ្ធផលសារធាតុប្រឆាំងអុកស៊ីតកម្មអាចពិពណ៌នាប្រតិកម្មមន្ទីរពិសោធន៍ កំហាប់សារធាតុចិញ្ចឹម...
អានអត្ថបទ →
អត្រាទង់ដែងនិងស័ង្កសី៖ លទ្ធផលខ្ពស់ ទាប និងបរិបទមន្ទីរពិសោធន៍
Trace Minerals Lab Interpretation 2026 Update Patient-Friendly A copper-to-zinc ratio is a calculated clue, not a diagnosis. The... អัตราส่วนទង់ដែងទៅស័ង្កសីគឺជាគន្លឹះដែលបានគណនា មិនមែនជាការវិនិច្ឆ័យរោគទេ។ ...
អានអត្ថបទ →ស្វែងរកមគ្គុទេសក៍សុខភាពទាំងអស់របស់យើង និង ឧបករណ៍វិភាគឈាមដោយ AI នៅ kantesti.net
⚕️ ការបដិសេធផ្នែកវេជ្ជសាស្ត្រ
អត្ថបទនេះមានគោលបំណងសម្រាប់ការអប់រំប៉ុណ្ណោះ ហើយមិនមែនជាការផ្តល់ដំបូន្មានផ្នែកវេជ្ជសាស្ត្រទេ។ សូមពិគ្រោះជាមួយអ្នកផ្តល់សេវាសុខភាពដែលមានសមត្ថភាពជានិច្ច សម្រាប់ការសម្រេចចិត្តអំពីការធ្វើរោគវិនិច្ឆ័យ និងការព្យាបាល។.
សញ្ញាទុកចិត្ត E-E-A-T
បទពិសោធន៍
ការពិនិត្យព្យាបាលដោយវេជ្ជបណ្ឌិតលើដំណើរការការបកស្រាយលទ្ធផលមន្ទីរពិសោធន៍។.
ជំនាញ
ផ្តោតលើវិទ្យាសាស្ត្រមន្ទីរពិសោធន៍ថា សញ្ញាសម្គាល់ (biomarkers) មានឥរិយាបថយ៉ាងដូចម្តេចក្នុងបរិបទព្យាបាល។.
ភាពមានសិទ្ធិអំណាច
សរសេរដោយវេជ្ជបណ្ឌិត Thomas Klein ជាមួយការពិនិត្យឡើងវិញដោយវេជ្ជបណ្ឌិត Sarah Mitchell និងសាស្ត្រាចារ្យវេជ្ជបណ្ឌិត Hans Weber។.
ភាពគួរឱ្យទុកចិត្ត
ការបកស្រាយដោយផ្អែកលើភស្តុតាង ជាមួយផ្លូវបន្តតាមដានច្បាស់លាស់ ដើម្បីកាត់បន្ថយការភ័យខ្លាច។.